Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 1/20 | 0.39 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | P2RY2 | P41231 | 4/20 | 0.37 |
| ▸ | P2RY4 | P51582 | 3/20 | 0.37 |
| ▸ | P2RY6 | Q15077 | 3/20 | 0.37 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.37 |
| ▸ | PNP | P00491 | 1/20 | 0.37 |
| ▸ | NT5E | P21589 | 1/20 | 0.36 |
| ▸ | KRAS | P01116 | 2/20 | 0.36 |
| ▸ | POLG | P54098 | 2/20 | 0.36 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.36 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.36 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.36 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.35 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.35 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.35 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30579769 | 0.89 | POLB (0.36) | TGM2FUT5POLBDCPSNT5E | |
| SCHEMBL31483545 | 0.87 | HINT1 (0.37) | DCPSNT5E | |
| SCHEMBL31108153 | 0.86 | TGM2 (0.39) | TGM2FUT5POLBP2RY2P2RY4 | |
| SCHEMBL31359442 | 0.85 | PNP (0.35) | PNPNT5E | |
| SCHEMBL30413097 | 0.85 | TGM2 (0.38) | TGM2FUT5POLBP2RY2P2RY4 | |
| SCHEMBL31359443 | 0.84 | TGM2 (0.56) | TGM2FUT5POLBP2RY2P2RY4 | |
| SCHEMBL31483544 | 0.83 | HINT1 (0.37) | TGM2FUT5POLBDCPSNT5E | |
| SCHEMBL23754698 | 0.81 | TGM2 (0.57) | TGM2FUT5P2RY2P2RY4P2RY6 | |
| SCHEMBL21010336 | 0.81 | TGM2 (0.57) | TGM2FUT5P2RY2P2RY4P2RY6 | |
| SCHEMBL20597816 | 0.81 | TGM2 (0.57) | TGM2FUT5P2RY2P2RY4P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12522630-B2 | MRNA cap analog and uses thereof | HANMI FINE CHEMICAL CO., LTD. (KR) | 2026-01-13 | — | — | US | disclosed |
| US-20250230183-A1 | MRNA CAP ANALOG AND USES THEREOF | HANMI FINE CHEMICAL CO., LTD. (KR) | 2025-07-17 | — | — | US | disclosed |
| WO-2025071359-A1 | MRNA CAP ANALOG AND USE THEREOF | 한미정밀화학 주식회사 | 2025-04-03 | — | — | WO | disclosed |
| EP-4506353-A1 | MRNA CAP ANALOG AND USES THEREOF | Hanmi Fine Chemical Co., Ltd. (KR) | 2025-02-12 | — | — | EP | disclosed |
| WO-2023191342-A1 | MRNA CAP ANALOG AND USES THEREOF | 한미정밀화학 주식회사 | 2023-10-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250230183-A1 | MRNA CAP ANALOG AND USES THEREOF | RNGTT, RNMT, CAP1 | TGM2 4453/4885FUT5 1822/4885POLB 1581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.